2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Stomach Ulcer
2
Stomach Neoplasms
2
Thoracic Diseases
1
Overweight
1
Obesity
1
Lung Neoplasms
1
Liver Neoplasms
1
Intestinal Polyps
1
Intestinal Neoplasms
1
Interventions
Exercise
25
Metformin
23
Tirzepatide
9
Resistance Training
8
Nutrition Assessment
8
Methods
8
Diet Therapy
8
Diet
8
Counseling
8
Surveys and Questionnaires
6
Early Intervention, Educational
6
Caloric Restriction
6
semaglutide
5
Liraglutide
5
Exenatide
5
Diet, Mediterranean
5
Blood Specimen Collection
5
Educational Status
4
Docosahexaenoic Acids
4
Bariatric Surgery
4
exemestane
3
Vitamin D
3
Therapeutics
3
Tamoxifen
3
Sugars
3
Standard of Care
3
Observation
3
Naltrexone
3
Letrozole
3
Dexamethasone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Obesity
×
(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled